Borchardt R T, Huber J A, Wu Y S
J Med Chem. 1976 Sep;19(9):1094-9. doi: 10.1021/jm00231a003.
Structural analogues of S-adenosyl-L-homocysteine (L-SAH), with modifications in the amino acid or base portions of the molecule, have been synthesized and evaluated for their abilities to inhibit the transmethylations catalyzed by catechol O-methyltransferase (COMT), phenylethanolamine N-methyltransferase (PNMT), histamine N-methyltransferase (HMT), hydroxyindole O-methyltransferase (HIOMT), and indoleethylamine N-methyltransferase (INMT). From these studies some interesting and potentially useful differences in the structural features of L-SAH needed to produce maximal binding to these methyltransferases were detected. This paper provides evidence that 8-azaadenosyl-L-homocysteine is a potent and selective inhibitor of HIOMT, whereas N6-methyladenosyl-L-homocysteine and N6-methyl-3-deazaadenosyl-L-homocysteine are selective inhibitors in INMT. In contrast, it was found that S-tubercidinyl-L-homocysteine was a fairly potent, but nonselective inhibitor of all of the methyltransferases studied. The differences and the similarities in the requirements for the binding of SAH to methyltransferases which were detected in this study and earlier studies from our laboratory, are described. The possibilites of utilizing differences in binding requirements for the design of SAH analogues as specific inhibitors of methyltransferases are discussed.
已合成了S-腺苷-L-高半胱氨酸(L-SAH)的结构类似物,这些类似物在分子的氨基酸或碱基部分有所修饰,并对其抑制儿茶酚O-甲基转移酶(COMT)、苯乙醇胺N-甲基转移酶(PNMT)、组胺N-甲基转移酶(HMT)、羟基吲哚O-甲基转移酶(HIOMT)和吲哚乙胺N-甲基转移酶(INMT)催化的转甲基作用的能力进行了评估。通过这些研究,发现了L-SAH产生与这些甲基转移酶最大结合所需的结构特征中一些有趣且可能有用的差异。本文提供的证据表明,8-氮杂腺苷-L-高半胱氨酸是HIOMT的有效且选择性抑制剂,而N6-甲基腺苷-L-高半胱氨酸和N6-甲基-3-脱氮杂腺苷-L-高半胱氨酸是INMT的选择性抑制剂。相比之下,发现S-杀结核菌素基-L-高半胱氨酸是所研究的所有甲基转移酶的相当有效的但非选择性抑制剂。描述了本研究以及我们实验室早期研究中检测到的SAH与甲基转移酶结合要求的差异和相似性。讨论了利用结合要求的差异设计SAH类似物作为甲基转移酶特异性抑制剂的可能性。